ArticleInvestigational new drugs2017

Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.

Manojkumar Bupathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.